41
Participants
Start Date
October 31, 2017
Primary Completion Date
January 18, 2024
Study Completion Date
January 18, 2024
commercially available lansoprazole
these participants will receive a one-time dose of lansoprazole followed by PK analysis and then once daily lansoprazole for 24 weeks
matched placebo
these participants will receive a one-time dose of lansoprazole followed by PK analysis and then once daily placebo for 24 weeks
Duke University Medical Center, Durham
Nemours Children's Specialty Care, Jacksonville
Thrasher Research Fund
OTHER
Nemours Children's Clinic
OTHER
Jason Lang, M.D., M.P.H.
OTHER